TP53 and osteosarcoma: There are many studies reported that human osteosarcomas can have a deletion, mutations, and/or rearrangements of the p53 gene, which may cause loss of normal constraints on cellular growth, cell cycle, senescence and metabolism [40–42].P53 also regulates osteogenic, chondrogenic, myogenic, adipogenic differentiation of MSCs [43, 44].